An Antisense Oligonucleotide Leads to Suppressed Transcription of Hdac2 and Long-Term Memory Enhancement

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Histone deacetylase 2 (HDAC2) acts as a memory suppressor; its inhibition can enhance cognition.
• Existing HDAC2 inhibitors lack specificity and have short half-lives.
• Antisense oligonucleotides (ASOs) provide a method for specific, long-lasting RNA target inhibition.

Purpose of the Study:

• To develop and evaluate an ASO for specific and long-lasting reduction of Hdac2 mRNA in mice.
• To determine the longevity, specificity, and mechanism of action of the Hdac2-targeted ASO.
• To investigate the effects of Hdac2 reduction on memory and gene expression.

Main Methods:

• Administration of a single Hdac2-targeted ASO injection into the central nervous system of mice.
• Assessment of Hdac2 protein and mRNA levels over 16 weeks.
• Object location memory tests to evaluate cognitive function.
• RNA sequencing (RNA-seq) analysis of brain tissues.
• Investigation of ASO interaction with Hdac2 regulatory RNA and RNA polymerase II.

Main Results:

• A single ASO injection led to persistent Hdac2 mRNA and protein reduction for 16 weeks.
• Object location memory was significantly enhanced for 8 weeks post-injection.
• RNA-seq confirmed Hdac2 specificity and identified altered expression in ERK and immune signaling pathways.
• The ASO suppressed a nonpolyadenylated Hdac2 regulatory RNA and caused transcriptional suppression via RNA polymerase II stalling.

Conclusions:

• Hdac2-targeted ASOs are effective in achieving specific, long-lasting reduction of Hdac2.
• This ASO approach demonstrates potential for cognitive enhancement and therapeutic applications in memory disorders.
• Transcriptional suppression of the target gene represents a novel mechanism of action for ASOs.